» Articles » PMID: 31129714

Trends in Psychiatric Disorders Prevalence and Prescription Patterns of Children in Alberta, Canada

Overview
Date 2019 May 27
PMID 31129714
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe the trends in the prevalence and incidence of children with psychiatric disorders, the types of medication prescribed, and the type of physician providing the prescriptions.

Method: This retrospective study linked six population-based administrative databases (2008-2015) in Alberta, Canada.

Results: The prevalence of paediatric psychiatric disorders increased from 12.6 per 100 population in 2008 to 15.0 per 100 population in 2015, while the incidence rate increased from 2.0 per 100 population to 2.2 per 100 population in the same period. The proportion of patients dispensed any psychiatric medication increased from 21.4% in 2008 to 28.2% in 2015. Over the same period, dispensations for antidepressants increased from 7.0% to 11.2% and stimulants to treat ADHD, from 11.9% to 15.9%. For antidepressants, general practitioners (GPs) wrote the highest proportion of prescriptions (44.3% in 2011-48.1% in 2015), while paediatricians wrote the lowest proportion (8.7% in 2011-11.0% in 2015) and the proportion by psychiatrists decreased from 33.4% in 2011 to 27.2% in 2015. For stimulants to treat ADHD, paediatricians were the most frequent prescribers (36.9% in 2011-39.3% in 2015) followed by GPs as the second most frequent (33.1% in 2011-33.5% in 2015), while psychiatrists were the least likely to prescribe stimulants for ADHD.

Conclusion: The increasing trend of psychiatric diagnoses and medication prescriptions in the paediatric population is evident using population-based administrative databases. The lack of safety and adverse consequences of medication use in this cohort warrants additional monitoring data.

Citing Articles

Prevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis.

Popit S, Serod K, Locatelli I, Stuhec M Eur Psychiatry. 2024; 67(1):e68.

PMID: 39381949 PMC: 11536208. DOI: 10.1192/j.eurpsy.2024.1786.


Recent trends in psychotropic medication use in children and adolescents in Ireland.

Parkin R, Bennett K, Nicholas F, Hayden J Eur Child Adolesc Psychiatry. 2024; 34(3):997-1009.

PMID: 39115684 DOI: 10.1007/s00787-024-02530-7.


Prevalence and Incidence Trends of Attention Deficit/Hyperactivity Disorder in Children and Youth Aged 1-24 Years in Ontario, Canada: A Validation Study of Health Administrative Data Algorithms: Tendances de la prévalence et de l'incidence du....

Butt D, Jaakkimainen L, Tu K Can J Psychiatry. 2023; 69(5):326-336.

PMID: 37960872 PMC: 11032092. DOI: 10.1177/07067437231213553.


The effect of internalized stigmatization on care burden in adolescent psychiatric patients and their parents.

Gumus F, Kacan H Front Psychiatry. 2023; 14:1192087.

PMID: 37654994 PMC: 10466785. DOI: 10.3389/fpsyt.2023.1192087.


A Review of Canadian Diagnosed ADHD Prevalence and Incidence Estimates Published in the Past Decade.

Espinet S, Graziosi G, Toplak M, Hesson J, Minhas P Brain Sci. 2022; 12(8).

PMID: 36009114 PMC: 9406225. DOI: 10.3390/brainsci12081051.


References
1.
Currie J, Stabile M, Jones L . Do stimulant medications improve educational and behavioral outcomes for children with ADHD?. J Health Econ. 2014; 37:58-69. PMC: 4815037. DOI: 10.1016/j.jhealeco.2014.05.002. View

2.
Doey T, Handelman K, Seabrook J, Steele M . Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years. Can J Psychiatry. 2007; 52(6):363-8. DOI: 10.1177/070674370705200605. View

3.
Katz L, Kozyrskyj A, Prior H, Enns M, Cox B, Sareen J . Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ. 2008; 178(8):1005-11. PMC: 2276558. DOI: 10.1503/cmaj.071265. View

4.
Merikangas K, Nakamura E, Kessler R . Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci. 2009; 11(1):7-20. PMC: 2807642. View

5.
Lakhan S, Hagger-Johnson G . The impact of prescribed psychotropics on youth. Clin Pract Epidemiol Ment Health. 2007; 3:21. PMC: 2100041. DOI: 10.1186/1745-0179-3-21. View